{"id":233302,"date":"2026-09-07T13:10:56","date_gmt":"2026-09-07T07:40:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=233302"},"modified":"2026-09-07T13:10:57","modified_gmt":"2026-09-07T07:40:57","slug":"amanta-healthcare-share-price-buy-hold-or-sell","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/","title":{"rendered":"Amanta Healthcare: Should You Buy, Hold, or Sell Right Now?"},"content":{"rendered":"<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Amanta Healthcare share price Rs 197.91 (NSE), more than doubled from its 52-week low. 52-week range Rs 92 to Rs 205.57. Q1 FY27 profit dipped slightly on capacity expansion costs.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">Amanta Healthcare Ltd share price is trading around Rs 198, close to its 52-week high of Rs 205.57 and more than double its 52-week low of Rs 92. Q1 FY27 revenue grew 5.4 percent year on year to Rs 68.8 crore, with EBITDA margin contracting to 21.13 percent from 22.81 percent, and net profit dipping slightly to Rs 3.3 crore from Rs 3.5 crore, driven by higher finance costs tied to a new solar term loan. The company is investing Rs 150 crore in capacity expansion, including its SteriPort facility, targeting peak revenue of Rs 425 crore by FY28. The stock trades at 51.53 times earnings, roughly in line with the pharma sector average near 50.8 times.<\/p>\n<\/div>\n<p>Amanta Healthcare share price is trading close to its 52-week high of Rs 205.57, with Amanta Healthcare share price around Rs 198 on the NSE, more than double its 52-week low of Rs 92. With a large capacity expansion weighing modestly on near-term margins in Q1 FY27, investors are asking whether this sterile injectable manufacturer is a stock to buy near its highs, a hold, or a sell.<\/p>\n<p>This Amanta Healthcare stock analysis walks through the Q1 FY27 numbers, the ongoing capacity expansion, valuation against the pharma sector, shareholding pattern and the technical setup, using figures sourced from company disclosures and investor communications.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=amanta_bhs\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#About_Amanta_Healthcare\" title=\"About Amanta Healthcare\">About Amanta Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Amanta_Healthcare_Share_Price_Today_Key_Levels\" title=\"Amanta Healthcare Share Price Today: Key Levels\">Amanta Healthcare Share Price Today: Key Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Amanta_Healthcare_Financial_Performance\" title=\"Amanta Healthcare Financial Performance\">Amanta Healthcare Financial Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Valuation_Check_Is_Amanta_Healthcare_Share_Price_Expensive\" title=\"Valuation Check: Is Amanta Healthcare Share Price Expensive?\">Valuation Check: Is Amanta Healthcare Share Price Expensive?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Technical_Signals_What_the_Chart_Shows\" title=\"Technical Signals: What the Chart Shows\">Technical Signals: What the Chart Shows<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Shareholding_Pattern\" title=\"Shareholding Pattern\">Shareholding Pattern<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Why_Investors_Are_Watching_Amanta_Healthcare\" title=\"Why Investors Are Watching Amanta Healthcare\">Why Investors Are Watching Amanta Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Risks_and_Factors_to_Watch\" title=\"Risks and Factors to Watch\">Risks and Factors to Watch<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Amanta_Healthcare_Share_Price_Target_What_the_Data_Suggests\" title=\"Amanta Healthcare Share Price Target: What the Data Suggests\">Amanta Healthcare Share Price Target: What the Data Suggests<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Amanta_Healthcare_Should_You_Buy_Hold_or_Sell_Right_Now\" title=\"Amanta Healthcare: Should You Buy, Hold, or Sell Right Now?\">Amanta Healthcare: Should You Buy, Hold, or Sell Right Now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Q1_Is_Amanta_Healthcare_a_good_stock_to_buy_right_now\" title=\"Q1. Is Amanta Healthcare a good stock to buy right now?\">Q1. Is Amanta Healthcare a good stock to buy right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Q2_What_is_the_Amanta_Healthcare_share_price_today\" title=\"Q2. What is the Amanta Healthcare share price today?\">Q2. What is the Amanta Healthcare share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Q3_What_is_the_Amanta_Healthcare_share_price_target\" title=\"Q3. What is the Amanta Healthcare share price target?\">Q3. What is the Amanta Healthcare share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Q4_What_does_Amanta_Healthcare_manufacture\" title=\"Q4. What does Amanta Healthcare manufacture?\">Q4. What does Amanta Healthcare manufacture?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Q5_What_is_Amanta_Healthcares_capacity_expansion_plan\" title=\"Q5. What is Amanta Healthcare&#8217;s capacity expansion plan?\">Q5. What is Amanta Healthcare&#8217;s capacity expansion plan?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/amanta-healthcare-share-price-buy-hold-or-sell\/#Q6_What_is_Amanta_Healthcares_market_capitalisation_and_PE_ratio\" title=\"Q6. What is Amanta Healthcare&#8217;s market capitalisation and PE ratio?\">Q6. What is Amanta Healthcare&#8217;s market capitalisation and PE ratio?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Amanta_Healthcare\"><\/span><strong>About Amanta Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Before deciding on Amanta Healthcare share price, it helps to understand the underlying business. Amanta Healthcare Ltd. manufactures sterile injectable pharmaceutical products, including large volume parenterals and small volume parenterals, serving hospitals and healthcare providers.<\/p>\n<p>The company is undertaking a significant Rs 150 crore capacity expansion, including its SteriPort facility and new small volume parenteral lines, aimed at more than doubling capacity and driving future revenue growth, though this investment phase has introduced some near-term cost pressure.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Amanta_Healthcare_Share_Price_Today_Key_Levels\"><\/span><strong>Amanta Healthcare Share Price Today: Key Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below summarises where Amanta Healthcare share price stands right now against its recent trading range and market value.<\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>Amanta Healthcare CMP (NSE)<\/td>\n<td>Rs 197.91<\/td>\n<\/tr>\n<tr>\n<td>Amanta Healthcare CMP (BSE)<\/td>\n<td>Rs 198.65<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 205.57<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 92.00<\/td>\n<\/tr>\n<tr>\n<td>Market Capitalisation<\/td>\n<td>Approximately Rs 756 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Amanta Healthcare share price is trading close to its 52-week high, having more than doubled from its 52-week low, reflecting investor confidence in the company&#8217;s capacity expansion story.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for Live Stock Data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Amanta_Healthcare_Financial_Performance\"><\/span><strong>Amanta Healthcare Financial Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Amanta Healthcare share price trend is closely tied to how these numbers evolve each quarter. Amanta Healthcare reported Q1 FY27 (June 2026 quarter) revenue of Rs 68.8 crore, up 5.4 percent year on year from Rs 65.3 crore, with EBITDA of Rs 14.5 crore, down slightly from Rs 14.9 crore, as EBITDA margin contracted to 21.13 percent from 22.81 percent. Net profit dipped to Rs 3.3 crore from Rs 3.5 crore, with the decline primarily driven by higher finance costs associated with a new solar term loan supporting the company&#8217;s captive power initiative.<\/p>\n<p>The company is advancing a Rs 150 crore capacity expansion, including its SteriPort Line 3 and new small volume parenteral facility, targeted for commissioning in Q2 FY27, with management guiding toward peak revenues of Rs 425 crore by FY28 once these facilities are fully operational.<\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Period<\/th>\n<th>Revenue<\/th>\n<th>Net Profit<\/th>\n<th>Comment<\/th>\n<\/tr>\n<tr>\n<td>Q1 FY27 (Jun 2026)<\/td>\n<td>Rs 68.80 crore<\/td>\n<td>Rs 3.30 crore<\/td>\n<td>+5.4% revenue; profit dipped slightly on higher finance costs<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_Check_Is_Amanta_Healthcare_Share_Price_Expensive\"><\/span><strong>Valuation Check: Is Amanta Healthcare Share Price Expensive?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Any view on Amanta Healthcare share price should start from these valuation multiples. Amanta Healthcare share price currently reflects a price to earnings ratio of about 51.53 times trailing earnings, roughly in line with the broader pharmaceutical sector average of roughly 50.8 times. The price to book ratio stands near 3.4 times, with return on equity at 7.46 percent.<\/p>\n<p>Debt to equity of 1.11 is elevated, reflecting the company&#8217;s ongoing capacity expansion funding. Given the significant capacity investment underway, this roughly in-line valuation reflects the market&#8217;s expectation that the expansion will drive meaningfully higher revenue once commissioned.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Signals_What_the_Chart_Shows\"><\/span><strong>Technical Signals: What the Chart Shows<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Price action here often foreshadows the next move in Amanta Healthcare share price. Amanta Healthcare share price is currently positioned just below its 52-week high of Rs 205.57, more than double its 52-week low of Rs 92, reflecting a very strong overall run over the past year. A stock trading this close to its high, despite a slight near-term profit dip tied to capacity expansion costs, typically signals the market looking past temporary investment-phase pressure toward future growth.<\/p>\n<p>Trading volumes remain moderate, so investors should track Amanta Healthcare share price alongside the commissioning progress of the SteriPort and SVP facilities in coming quarters, rather than reacting to the slight Q1 FY27 profit dip alone at these technical levels.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Amanta Healthcare&#8217;s live price and technical levels.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Shareholding_Pattern\"><\/span><strong>Shareholding Pattern<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Shifts here can influence Amanta Healthcare share price more than headline news on some sessions. Amanta Healthcare is a promoter-led sterile injectable pharmaceutical manufacturer undertaking a significant capacity expansion. A detailed current promoter, FII and DII percentage breakdown was not consistently available across sources at the time of writing and should be verified on the company&#8217;s latest exchange filing.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Amanta_Healthcare\"><\/span><strong>Why Investors Are Watching Amanta Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Significant capacity expansion underway:<\/strong> The Rs 150 crore investment in SteriPort and new SVP lines is targeted to more than double capacity and support peak revenue of Rs 425 crore by FY28.<\/li>\n<li><strong>Continued revenue growth:<\/strong> Q1 FY27 revenue still grew 5.4 percent year on year even amid the capacity investment phase.<\/li>\n<li><strong>Strong stock performance over the past year:<\/strong> The stock has more than doubled from its 52-week low, reflecting investor confidence in the expansion story.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Risks_and_Factors_to_Watch\"><\/span><strong>Risks and Factors to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Near-term margin pressure from expansion costs:<\/strong> EBITDA margin contracted and profit dipped slightly due to higher finance costs tied to the capacity expansion, a trend that could continue until the new facilities are commissioned.<\/li>\n<li><strong>Commissioning delay risk:<\/strong> The SteriPort Line 3 has already faced a four to five month delay, and further delays could push back the expected revenue benefits.<\/li>\n<li><strong>Elevated leverage from expansion funding:<\/strong> A debt to equity ratio of 1.11 reflects the capital being deployed for the expansion, adding financial risk during the investment phase.<\/li>\n<li><strong>Working capital and input cost volatility:<\/strong> Sterile product manufacturing involves long working capital cycles and exposure to polymer input cost volatility.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Amanta_Healthcare_Share_Price_Target_What_the_Data_Suggests\"><\/span><strong>Amanta Healthcare Share Price Target: What the Data Suggests<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Until then, Amanta Healthcare share price remains best tracked through live, verified data rather than a single fixed number. Amanta Healthcare does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time. What the data shows is a company investing significantly in capacity expansion, trading roughly in line with the pharma sector near its 52-week high.<\/p>\n<p>Investors who want live, updated research can check the Univest Screener, and should consult a SEBI-registered investment adviser for guidance tailored to their own goals.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Amanta_Healthcare_Should_You_Buy_Hold_or_Sell_Right_Now\"><\/span><strong>Amanta Healthcare: Should You Buy, Hold, or Sell Right Now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This is the core question behind Amanta Healthcare share price right now. The Amanta Healthcare buy or sell decision depends on whether the SteriPort and SVP expansions deliver on schedule.<\/p>\n<p><strong>The case for buying:<\/strong> Investors who believe in the company&#8217;s capacity expansion story and are comfortable with near-term margin pressure during the investment phase may find the current level, near its 52-week high, worth considering.<\/p>\n<p><strong>The case for holding:<\/strong> Existing shareholders who already track Amanta Healthcare&#8217;s expansion progress may prefer to stay invested through the commissioning phase.<\/p>\n<p><strong>The case for waiting:<\/strong> Investors wanting to see the new facilities successfully commissioned and contributing to revenue before committing fresh capital may prefer to wait for that confirmation.<\/p>\n<p>Weigh this against your own risk tolerance and consult a SEBI-registered investment adviser if unsure.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Amanta Healthcare share price reflects a sterile injectable pharmaceutical manufacturer investing significantly in capacity expansion, with Q1 FY27 profit dipping slightly on higher finance costs even as revenue continued to grow, trading close to its 52-week high. This article is for informational purposes and not a personalised investment recommendation.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"Q1_Is_Amanta_Healthcare_a_good_stock_to_buy_right_now\"><\/span><strong>Q1. Is Amanta Healthcare a good stock to buy right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Amanta Healthcare&#8217;s Q1 FY27 profit dipped slightly to Rs 3.3 crore due to higher finance costs tied to its Rs 150 crore capacity expansion, even as revenue grew 5.4 percent. This suits investors who believe in the expansion&#8217;s targeted peak revenue of Rs 425 crore by FY28.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q2_What_is_the_Amanta_Healthcare_share_price_today\"><\/span><strong>Q2. What is the Amanta Healthcare share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Amanta Healthcare share price is trading around Rs 198 on the NSE, close to its 52-week high of Rs 205.57. The stock&#8217;s 52-week low is Rs 92.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q3_What_is_the_Amanta_Healthcare_share_price_target\"><\/span><strong>Q3. What is the Amanta Healthcare share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Amanta Healthcare does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time. Investors can check live research on the Univest Screener and consult a SEBI-registered adviser.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q4_What_does_Amanta_Healthcare_manufacture\"><\/span><strong>Q4. What does Amanta Healthcare manufacture?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Amanta Healthcare manufactures sterile injectable pharmaceutical products, including large volume parenterals and small volume parenterals, serving hospitals and healthcare providers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q5_What_is_Amanta_Healthcares_capacity_expansion_plan\"><\/span><strong>Q5. What is Amanta Healthcare&#8217;s capacity expansion plan?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Amanta Healthcare is investing Rs 150 crore in capacity expansion, including its SteriPort Line 3 and a new small volume parenteral facility, targeted for commissioning in Q2 FY27, aiming for peak revenue of Rs 425 crore by FY28.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q6_What_is_Amanta_Healthcares_market_capitalisation_and_PE_ratio\"><\/span><strong>Q6. What is Amanta Healthcare&#8217;s market capitalisation and PE ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Amanta Healthcare has a market capitalisation of approximately Rs 756 crore and trades at a price to earnings ratio of about 51.53 times, roughly in line with the pharmaceutical sector average PE of roughly 50.8 times.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Amanta Healthcare share price explained: capacity expansion weighing on near-term margins. A balanced buy, hold or sell view.<\/p>\n","protected":false},"author":36,"featured_media":233301,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-233302","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["233301"],"_edit_lock":["1788766860:36"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["79"],"rank_math_title":["Amanta Healthcare Share Price: Buy or Sell"],"rank_math_description":["Amanta Healthcare share price today, capacity expansion weighing on near-term margins, with a balanced buy, hold or sell view."],"rank_math_focus_keyword":["Amanta Healthcare share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["36"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["41897"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/amanta-healthcare-share-price-buy-hold-or-sell.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/233302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=233302"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/233302\/revisions"}],"predecessor-version":[{"id":233411,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/233302\/revisions\/233411"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/233301"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=233302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=233302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=233302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}